Anticancer Properties of Halogenated Pyrrolo[3,2-d]pyrimidines with Decreased Toxicity via N5 Substitution.

about

Anticancer Properties of Halogenated Pyrrolo[3,2-d]pyrimidines with Decreased Toxicity via N5 Substitution.

Item

http://www.wikidata.org/entity/Q47385841

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Anticancer Properties of Halog ...... Toxicity via N5 Substitution.

@en

Anticancer Properties of Halog ...... Toxicity via N5 Substitution.

@nl

type

Item

label

Anticancer Properties of Halog ...... Toxicity via N5 Substitution.

@en

Anticancer Properties of Halog ...... Toxicity via N5 Substitution.

@nl

prefLabel

Anticancer Properties of Halog ...... Toxicity via N5 Substitution.

@en

Anticancer Properties of Halog ...... Toxicity via N5 Substitution.

@nl

P1476

Anticancer Properties of Halog ...... Toxicity via N5 Substitution.

@en

P2093

Brandon Cooper

http://www.w3.org/2001/XMLSchema#string

Brian M Cawrse

http://www.w3.org/2001/XMLSchema#string

Eun Yong Choi

http://www.w3.org/2001/XMLSchema#string

Rena S Lapidus

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic treatment of solid tumours: a review of clinical trials

Synthetic and biological studies of tubulin targeting c2-substituted 7-deazahypoxanthines derived from marine alkaloid rigidins

Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: novel VEGFR2 kinase inhibitors binding to inactive kinase conformation

Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold

Structure of Hepatitis C Virus Polymerase in Complex with Primer-Template RNA

Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity

Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II study.

7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.

P304

178-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201700641

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Katherine L. Seley-Radtke

P577

2017-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29193845

http://www.w3.org/2001/XMLSchema#string

P932

5912934

http://www.w3.org/2001/XMLSchema#string